STOCKHOLM, March 31 (Reuters) - Swedish medical technology group Elekta EKTAb.ST said on Thursday it had signed an eight-year partnership deal worth more than $100 million with Australian radiotherapy firm GenesisCare.
Elekta said in a statement it would book no part of the agreement in its fiscal fourth quarter.
The deal includes the acquisition of solutions across Elekta's portfolio, and the company expects GenesisCare to order its new MRI-guided linear accelerator when it becomes available on the market in 2017.